The FDA gave Perrigo its final approval on Tuesday to market the store-brand equivalent to Children's Zyrtec Allergy Syrup, an indoor/outdoor allergy drug for children aged 2 years and older. The company expects to start shipments of this generic version during the upcoming cough/cold/flu season.

Full Story:
Drug Store News

Related Summaries